Global Farm Animal Health Industry by 2026-North America Leading | Business Wire China

2021-12-08 11:06:25 By : Ms. Sophie Lee

DUBLIN--(BUSINESS WIRE)--The "Farm Animal Health Market-Growth, Trends, COVID-19 Impact and Forecast (2021-2026)" report has been added to's products.

The farm animal health care market is expected to grow at a compound annual growth rate of 8.2% during the forecast period (2021-2026).

During the forecast period, parasiticides represent a high growth opportunity for farm animal health

Parasiticides are in great demand and are used to treat many diseases of farm animals. With the development of animal husbandry, the demand for veterinary drugs is expected to increase excessively. Animals are more susceptible to internal parasites, which usually include caterpillars, lungworms, liver flukes, and coccidia. External parasites that may be harmful to animals include horn flies, lice, and grubs. Parasitic diseases in animals can cause disturbances in health and reproduction, impaired growth, and decreased productivity.

Therefore, for better animal health, pesticides are inevitable. Commonly used pesticides include levamisole, fenbendazole, oxfendazole, albendazole, moxidectin, eprinomectin, etc. Most major companies are focusing on the innovation of pesticide products , In order to develop advanced oral dosage forms of pesticides. For example, in November 2019, Ceva launched Salmoporc, a Salmonella vaccine for pigs in the UK and Ireland. Salmoporc provides protection against Salmonella typhimurium and its single-phase variants. It can be given to piglets orally or injected into sows under the skin. This increases the company's market growth opportunities in different countries.

North America leads the farm animal health market

North America is one of the main contributors to the region's agriculture, animal husbandry, technological advancement, and implementation of farm animal health and welfare. The United States is one of the most developed economies in the world. It currently occupies a major share of the farm animal health market and is expected to follow the same trend during the forecast period. The federal regulations and state regulations of the United States are responsible for the registration and introduction of new animal health products in the country.

The registration, introduction or import of such products in the country are strictly carried out under the supervision of these regulatory agencies. There are different tests and certifications that should be cleared. Veterinary vaccines in the United States are regulated by the Center for Veterinary Biological Products (CVB) of the Animal and Plant Health Inspection Service (APHIS). CVB grants establishment and product licenses to animal health companies to manufacture and sell veterinary biologics.

In the United States, the development of vaccines includes the development of live vector vaccines, nucleic acid-mediated vaccines, and live gene deletion vaccines. Boehringer Ingelheim launched a poultry vaccine product HatchPak IB H120TM NeO in 2018, which is a freeze-dried live attenuated bronchitis virus designed to simplify the vaccination of chickens against bronchitis virus. In addition, in June 2020, Huvepharma EOOD's product "Vetmulin 12.5%" was approved by the US FDA, which is an antibiotic used to treat swine dysentery. Therefore, these will promote the growth of the regional market.

4.2 Introduction to market drivers and constraints

4.3.1 Advanced technology leads animal health innovation

4.3.2 There are more and more initiatives by governments and animal welfare associations

4.3.3 Increase productivity with the risk of emerging zoonotic diseases

4.4.2 Increasing the cost of animal testing and veterinary services

7 Market opportunities and future trends

For more information about this report, please visit Laura Wood, Senior Press Manager US Eastern Time Office Hours Call 1-917-300-0470 US/Canada Toll Free 1-800-526-8630 GMT Office Hours Call +353-1- 416- 8900 Laura Wood, Senior Press Manager US Eastern Time Office Hours Call 1-917-300-0470 US/Canada Toll Free 1-800-526-8630 GMT Office Hours Call +353-1- 416- 8900